Interview: Ken D Foster’s Voices of Courage Show
115: The Courage to Influence and Stay Calm with Harry Glorikian and Julie Potiker
 Today we discuss having the courage to find our voice and seek the truth at all costs while staying calm in the midst of chaos.  My first guest, Harry Glorikian, is an influential global business expert with more than three decades of experience building…
Recording of the show can be found at:
-
- TuneIn –Â https://bit.ly/38ADp6f
- Stitcher –Â https://bit.ly/2UM4hcN
- Listen Notes –Â https://bit.ly/2Z4NBk0
- Player FM –Â https://bit.ly/3f8gbqt
- Apple Podcast –Â https://apple.co/2O0O28D
- BBS Radio –Â https://bit.ly/2O2rBjx
About Harry Glorikian
Harry Glorikian is an influential global business expert with more than three decades of experience building successful ventures in North America, Europe, Asia and the rest of the world. Harry is well known for achievements in life sciences, healthcare, diagnostics, healthcare IT and the convergence of these areas. He is a sought-after speaker, frequently quoted in the media, and regularly asked to assess, influence, and be part of innovative concepts and trends.
He is currently a General Partner at New Ventures Funds (NV). Before joining NV Funds, he served as an Entrepreneur In Residence to GE Ventures – New Business Creation Group. He currently serves on the board of GeneNews Ltd. He also serves on the advisory board of Evidation Health (a digital health startup launched with support from GE Ventures), and several other companies. He is also a co-founder and an advisory board member of DrawBridge Health (a revolutionary diagnostics startup launched with support from GE Ventures).
Harry holds an MBA from Boston University and a bachelor’s degree from San Francisco State University. Harry has addressed the NIH, Molecular Medicine Tri-Conference, World Theranostics Congress and other audiences, worldwide. He has authored numerous articles, appeared on CBS Evening News and been quoted regularly by Dow Jones, The Boston Globe, Los Angeles Times, London Independent, Medical Device Daily, Science Magazine, Genetic Engineering News and many others.